The expression of KDM1A was significantly upregulated in some stages of pancreatic adenocarcinoma (PAAD; Figure S1L) and associated with poor survival rate of PAAD patients (Figure S2F), but no significant difference was observed in KDM1A expression between PAAD tissues and NATs (Figure S1I). Here, KDM1A is linked to pancreatic adenocarcinoma.